Assenagon Asset Management S.A.

Position in TARA — Protara Therapeutics, Inc.

CIK 1546007 SENNINGERBERG, N4

Position in TARA

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$229,024

-$2,728,281 QoQ

Shares Held

59,954

-89.4% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 120 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. TARA ranks #63 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd.	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc.	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$229,024	59,954	-89.4%	Shares	Sole	2026-08-21
2026-03-31	$2,957,305	567,621	+84.1%	Shares	Sole	2026-04-20
2025-12-31	$1,643,420	308,334	+0.3%	Shares	Sole	2026-01-09
2025-09-30	$1,337,285	307,422	+1841.9%	Shares	Sole	2025-10-07
2023-12-31	$29,683	15,831	0.0%	Shares	Sole	2024-01-17
2023-09-30	$26,437	15,831	-45.5%	Shares	Sole	2023-11-06
2023-06-30	$69,431	29,051	+67.6%	Shares	Sole	2023-07-25
2023-03-31	$54,261	17,336	0.0%	Shares	Sole	2023-04-18
2022-12-31	$46,460	17,336	-70.3%	Shares	Sole	2023-01-12
2022-09-30	$172,831	58,389	0.0%	Shares	Sole	2022-10-27
2022-06-30	$171,079	58,389	+33.5%	Shares	Sole	2022-07-27
2022-03-31	$223,516	43,741	—	Shares	Sole	2022-04-25
No filing history on record for this holder in this stock.